Company / Revenue per Share
Edwards Lifesciences Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$10.45
FY2025
5-year range
$7.34 / $10.45
FY2021-FY2025
Trend
+15.5%
vs FY2024
Sector context
#116 of 153
Health Care
What the data says
Edwards Lifesciences's revenue per share of $10.45 is lower than 76% of companies in the Health Care sector (FY2025). Revenue per Share has increased for 3 consecutive years, from $7.34 in FY2022 to $10.45 in FY2025.
Based on SEC 10-K filings.
10.45 in FY2025 with a 5-year CAGR of +8.3%.
Improved from $8.60 to $10.45 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +12.5%
- 5-Year CAGR
- +8.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 24% in Health CareTop 76% of 153This company $10.45 Sector average $124.28
▼
-91.6% below sector average
Key checks
Key Insights
- Edwards Lifesciences's revenue per share has grown for 3 consecutive years.
- In FY2025, revenue per share increased 15.5% year-over-year.
- Ranks #116 out of 153 companies in the Health Care sector.
- Peak revenue per share was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 3.16 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.45 | +15.5% |
| FY2024 | $9.05 | +5.2% |
| FY2023 | $8.60 | +17.2% |
| FY2022 | $7.34 | -12.5% |
| FY2021 | $8.38 | +19.3% |
| FY2020 | $7.03 | -66.2% |
| FY2019 | $20.79 | +16.0% |
| FY2018 | $17.92 | +10.4% |
| FY2017 | $16.23 | +15.9% |
| FY2016 | $14.01 | -39.5% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026